A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days
Clinical trial NCT00002136 · COMPLETED
Trial details
- NCT number
- NCT00002136
- Sponsor
- Daiichi Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.